ORAGENICS, INC. (OGEN) Free cash flow 2016–2023
ORAGENICS, INC. (OGEN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$7.4MFY2023 · since FY2016: -$7.2M → -$7.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$7.4M | +51.4% |
| FY2022 | -$15.3M | — |
| FY2020 | -$17.0M | -29.2% |
| FY2019 | -$13.1M | — |
| FY2017 | -$6.4M | +11.0% |
| FY2016 | -$7.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More OGEN financial trends
OGEN RevenueOGEN Net incomeOGEN Net marginOGEN Gross profitOGEN Gross marginOGEN Operating incomeOGEN Operating marginOGEN Operating cash flowOGEN Capital expendituresOGEN Return on equityOGEN Stock buybacksOGEN Dividends paidOGEN Total assetsOGEN Total liabilitiesOGEN Shareholders’ equityOGEN overview →